GCG and cancer: Pan-cancer analyses based on scRNA-seq, including renal cancer, have identified upregulation of glycolysis/gluconeogenesis, propanoate metabolism, steroid hormone biosynthesis, tricarboxylic acid (TCA) cycle, and glucagon signaling pathways across most cancers, while the biosynthesis of glycosaminoglycans is downregulated [192].